Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system

Chemical Immunology

Volumn 75, Issue , 2000, Pages 121-145

  Okamoto, Hiroshi ^a   Takasawa, Shin ^a   Nata, Koji ^a   Kato, Ichiro ^a   Tohgo, Akira ^a   Noguchi, Naoya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; ALLOXAN; AUTOANTIBODY; CALCIUM ION; CD38 ANTIGEN; CYSTEINE; GLUCOSE; HYDROLASE; INOSITOL TRISPHOSPHATE; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; STREPTOZOCIN; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONFERENCE PAPER; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE STRUCTURE; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE METABOLISM; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0033967246     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058766     Document Type: Conference Paper

References (19)

1. Ashcroft FM, Harrison DE, Ashcroft SJH: Glucose-induced closure of single potassium channels in isolated rat pancreatic β-cells. Nature 1984;312:446-448.
2. ++ mobilization in pancreatic islets; in Yamashina I (ed): First IUBMB Conference: Biochemistry of Diseases. Nagoya, Bridge Ltd, 1992, p 218.
3. Takasawa S, Nata K, Yonekura H, Okamoto H: Cyclic ADP-ribose in insulin secretion from pancreatic β cells. Science 1993;259:370-373.
4. Takasawa S, Tohgo A, Noguchi N, Koguma T, Nata K, Sugimoto T, Yonekura H, Okamoto H: Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem 1993;268:26052-26054.
5. Okamoto H, Takasawa S, Tohgo A: New aspects of the physiological significance of NAD, poly-ADP-ribose and cyclic ADP-ribose. Biochimie 1995;77:356-363.
6. Kato I, Takasawa S, Akabane A, Tanaka O, Abe H, Takamura T, Suzuki Y, Nata K, Yonekura H, Yoshimoto T, Okamoto H: Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic β cells: Enhanced insulin secretion in CD38 transgenic mice. J Biol Chem 1995;270:30045-30050.
7. Okamoto H, Takasawa S, Tohgo A, Nata K, Kato I, Noguchi N: Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38: Inhibition of hydrolysis by ATP and the physiological significance. Methods Enzymol 1997;280:306-318.
8. Okamoto H, Takasawa S, Nata K: The CD38-cyclic ADP-ribose signalling system in insulin secretion: Molecular basis and clinical implications. Diabctologia 1997;40:1485-1491.
9. Okamoto H: Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 1981;37:43-61.
10. Okamoto H: Molecular basis of experimental diabetes: Degeneration, oncogenesis, and regeneration of pancreatic B-cells of islets of Langerhans. Bioessays 1985;2:15-21.
11. Okamoto H: The molecular basis of experimental diabetes; in Okamoto H (ed): Molecular Biology of the Islets of Langerhans. Cambridge, Cambridge University Press, 1990, pp 209-231.
12. Okamoto H: Okamoto model for B-cell damage: Recent advances; in Shafrir E (ed): Lessons from Animal Diabetes. VI. Boston, Birkhäuser, 1996, pp 97-111.
13. Yamamoto H, Okamoto H: Protection by picolinamide, a novel inhibitor of poly(ADP-ribose)-synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Biochem Biophys Res Commun 1980;95:474-481.
14. Yamamoto H, Uchigata Y, Okamoto H: Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose)synthetase in pancreatic islets. Nature 1981;294:284-286.
15. Uchigata Y, Yamamoto H, Kawamura A, Okamoto H: Pzrotection by Superoxide dismutase, catalase, and poly(ADP-ribosc)synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem 1982;257:6084-6088.
16. Uchigata Y, Yamamoto H, Nagai H, Okamoto H: Effect of poly(ADP-ribose)synthetase inhibitor administration to rats before and after injection of alloxan and Streptozotocin on islet proinsulin synthesis. Diabetes 1983;32:316-318.
17. Shima K, Hirota M, Sato M, Numoto S, Oshima I: Effect of poly(ADP-ribose)synthetase inhibitor administration to streptozotocin-induced diabetic rats on insulin and glucagon contents in their pancreas. Diabetes Res Clin Pract 1987;3:135-142.
18. Burkart V, Wang Z-Q, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H: Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin. Nature Med 1999;5:314-319.
19. Masutani M, Suzuki H, Kamada N, Watanabe M,Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T: Poly(ADP-ribose) polymerase genedisruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999;96:2301-2304.